Axios Pro: Health Tech Deals
May 05, 2022
Axios Pro Exclusive Content

Happy Friday eve, Health Tech friends.

⚔️ Situational awareness: In today’s drug-pricing drama, J&J is suing a drug-benefit middleman, SaveOnSP, alleging it exploited a program meant to help patients save money on pricey out-of-pocket prescription drugs, per the WSJ.

1 big thing: Olive sees high-level staff departures

Illustration of the Olive logo with an emoji sweatdrop
Illustration: Sarah Grillo/Axios

Olive is losing some of its top talent, three sources familiar with the matter tell Erin.

Why it matters: Valued at $4 billion by leading firms including Tiger Global and General Catalyst, Olive is the venture darling of health care automation — a process intended to cut costs and put more resources toward patient care.

By the numbers: Within roughly the last month, at least 20 employees have left the company, according to the three sources and LinkedIn data. Departures include people in the following roles...

  • Executive vice president and general manager
  • Senior director of partner programs for analytics and operations
  • Director of data engineering
  • Chief marketing officer
  • Vice president of product
  • Plus: engineering manager, two strategic account leads, partnerships program lead, strategic account executive, senior product manager, product manager, product manager of revenue cycle, revenue operations analyst, product owner, financial analyst, two software engineering team leads, software engineer and data scientist.
  • "It's an exodus," one current employee tells Erin.

Where it stands: After expanding its employee base by roughly 340% between 2020 and February 2022, according to LinkedIn data, Olive froze hiring in March because of issues maintaining its budget, three people tell Erin.

What they're saying: "People here walk around like we’re immune to these market dynamics," another current employee tells Axios. "And we aren't. We’ve bought into our own hype."

  • In response to a summary of this story, an Olive spokesperson said the company "did not freeze hiring in March, and in fact hired more than 50 Olivians during the month" and added that it was "proud to employ more than 1,300 talented and passionate people, with over 250 hired since the start of 2022."

Flashback: Earlier this month, Axios published an investigation alleging the company's promises to save health systems millions of dollars with its automation software don't deliver.

View archive